Skip to search.
 BSE  0.00% NSE Down 0.62%
Streaming
Ticker Tape: On

Amicus Therapeutics, Inc. (FOLD)

-NasdaqGM

2.52 Down 0.03(0.98%) 1:30AM

Add to Portfolio
Prev Close:2.54
Open:2.57
Bid:N/A
Ask:2.53 x 17700
1y Target Est:4.70
Beta:1.93
Next Earnings Date: 5-Aug-13FOLD Earnings announcement
Day's Range:2.50 - 2.65
52wk Range:2.30 - 6.89
Volume:610,563
Avg Vol (3m):428,262
Market Cap:124.82M
P/E (ttm):N/A
EPS (ttm):-1.10
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for FOLD at this time.

Comparison

Symbol% ChgMkt Cap
FOLDDown 0.98%124.82M
RHHBYN.MXUp 1.64%2.74T
SHP.LDown 0.33%11.52B
SUNPHARMA.NSDown 0.08%1.00T
GILD.MXUp 2.37%1.02T
» More Competitors

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):11.85
Ex-Dividend Date:N/A
» More Key Statistics

Analysts

Annual EPS Est (Dec-13) :-1.41
Quarterly EPS Est (Jun-13) :-0.35
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Amicus Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs known as pharmacological chaperones. View More
Company Profile | Industry
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback